Stress escalates silently. By the time it's visible from the outside — to a partner, a colleague, a caregiver — capacity has usually already been exceeded. Most wearables measure state after the fact; almost none intervene at the moment regulation is still possible.
Somatag is a discreet, screen-free, body-worn control point — designed to be felt, not looked at. Existing wearables provide the sensing; the SOMA decision layer classifies what's changing and chooses the least-burden response; Somatag delivers a private haptic cue and captures whether it helped.
Personalization is the decision layer's job: adaptive thresholds tuned to an individual's baseline rather than generic norms, with multi-signal fusion to keep false positives from eroding trust — because one ignored false alarm costs more adherence than ten quiet days.
Active R&D, with manufacturing-partner discussions underway. This one is still being built — the case study will get an outcome section once there's a pilot to report on.
Every research-driven product faces the same tension: waiting for clinical-grade evidence means shipping nothing for years; shipping without evidence means becoming another wellness gadget. The answer is two tracks, run deliberately. A low-burden behavioral track ships now — real interventions in real homes. A sensing-precision track earns its claims on top of that data, using devices people already own.
Shipping is how the research gets its data. The research is why what ships can be trusted.